POSTER SESSION III Tuesday, March 9, 2004   —  9:30 AM - 12:00 Noon Exhibit Hall B and C LIVER AND PANCREAS PATHOLOGY 166 Decreased Expression of Some Antigens (CD10, CD26, CEA, GGT) but Not Others (BSEP, cMOAT) at the Canaliculus May Distinguish FIC1 / ATP8B1 Disease (Benign Recurrent Intrahepatic Cholestasis, Progressive Familial Intrahepatic Cholestasis, Type 1) from Other Forms of Intrahepatic Cholestasis and from Obstructive and Ductopenic Cholestasis (1289) NJ Meara, AC Rayner, RHJ Houwen, PGJ Nikkels, BC Portmann, SS Strautnieks, RJ Thompson, LN Bull, AS Knisely - Institute of Liver Studies, King's College Hospital, London, United Kingdom; Wilhelmina Kinderziekenhuis, Utrecht, Netherlands; University of California San Francisco, San Francisco, CA 167 Proliferation of PDX-1 Transcription Factor Positive Oval Cells in the Pancreas of Copper Deficient Rats but Not after Duct Ligation (1276) P Kashireddy, MS Rao - The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 168 Beneficial Effects of Bombesin and Neurotensin on Liver Histology and Oxidative Status in Bile Duct Ligated Rats (1312) CD Scopa, SF Assimakopoulos, CD Georgiou, CE Vagianos - University of Patras Medical School, Patras, Greece 169 Cholangitis: A Histologic Classification Based on Pattern of Injury in Liver Needle Biopsies (1287) Y Li, G Ayata, B Banner - UMass Memorial Healthcare (UMMHC), Worcester, MA 170 Glycogenic Hepatopathy: An Under-Recognized Hepatic Complication of Diabetes Mellitus (1248) YY Chen, EM Brunt, SM Jakate, YC Liu, M Torbenson, MM Yeh, LD Ferrell - University of California, San Francisco, CA; St Louis University, St Louis, MO; Rush University Medical Center, Chicago, IL; MetroHealth Medical Center, Cleveland, OH; Johns Hopkins Hospital, Baltimore, MD; University of Washington, Seattle, WA 171 The Impact of HIV Infection and Diabetes Mellitus on Steatosis and Fibrosis in HCV Infection, Histopathologic Assessment and Comparison (1292) MP Murray, K Marks, F Ahmed, LM Petrovic - New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY 172 Correlation of Viral Load and Histological Grade in Hepatitis C Virus Infected Patients (1316) GH Wang, GY Yang, G Sidhu - New York University School of Medicine; New York Harbor Healthcare System and New York University School of Medicine, New York, NY 173 Thymic Stromal Lymphopoetin (TSLP) Transgenic Mice Develop Mixed Cryoglobulinemia and Hepatitis Mimicking Human Chronic Hepatitis C Disease (495) J Kowalewska, AS Muhlfeld, KL Hudkins, AG Farr, MM Yeh, CE Alpers - Univ. of Washington, Seattle, WA 174 Increased Bax/Bcl-2 Ratio Upregulates Caspase-3 and Increases Apoptosis in Cases of Chronic Hepatitis Type B and C (1314) AC Tsamandas, C Gogos, K Thomopoulos, T Kourelis, K Tepetes, T Petsas, C Karatza, DS Bonikos - University of Patras, Patras, Greece 175 Alterations of Bax/Bcl-2 Ratio Upregulates Caspase-3 and Modifies Apoptosis in Experimental Liver Fibrosis (1274) C Kalogeropoulou, I Tsota, P Zabakis, T Kourelis, P Ravazoula, DS Bonikos, D Kardamakis, T Petsas, K Tepetes, AC Tsamandas - University of Patras School of Medicine, Patras, Greece 176 Hepatic Necrotizing Cryptic Candidiasis in Hematological Malignancies (1269) S Jakate, D Treaba, P Verma, M Hayden - Rush University Medical Center, Chicago, IL; Northwestern Memorial Hospital, Chicago, IL 177 Severe Hepatic Sinusoidal Obstruction Associated with Oxaliplatin-Based Chemotherapy in Patients with Metastatis Colorectal Cancer (1307) L Rubbia-Brandt, V Audard, P Sartoretti, AD Roth, C Brezault, M Lecharpentier, B Dousset, P Morel, O Soubrane, G Mentha, B Terris - University Hospital, Geneva, Switzerland; Cochin Hospital, Paris, France 178 Should Potential Living Donors (PLDs) Undergo Liver Biopsy before Acceptance for Liver Transplantation? (1246) C Changsri, TT Tran, S Colquhoun, P Martin, FF Poordad, N Nissen, JM Vierling, C Shackleton, SA Geller - Cedars-Sinai Medical Center, Los Angeles, CA 179 Clinical Pathologic Study of 47 Patients with Cirrhosis and Hepatocellular Carcinoma Treated with Orthotopic Liver Transplantation (1239) O Alassi, R Nakhleh, D Schultz, N Parveen, I Bansal, M Abouljoud, C Ma - Henry Ford Hospital, Detroit, MI; Mayo Clinic, Jacksonville, FL 180 Liver Transplant Failure Due to Bile Duct Complication; Review of Ten Cases Reaffirming the Ischemic Nature of Duct Injury (1295) RE Nakhleh, M Krishna - Mayo Clinic Jacksonville, Jacksonville, FL 181 Liver Transplantation in Pre-Cirrhotic Chronic Biliary Tract Disease: Portal Hypertension Is Frequently Associated with Nodular Regenerative Hyperplasia and Obliterative Portal Venopathy (1237) SC Abraham, AM Krasinskas - Mayo Clinic, Rochester, MN; University of Pittsburgh Medical Center, Pittsburgh, PA 182 Phenotypic Alterations of Periportal Hepatocytes in Allograft Liver: The Utility of Cytokeratin 7 in Ductopenic Rejection (1305) RD Ranguelov, PE Swanson, AM Larson, MP Upton, MM Yeh - University of Washington School of Medicine, Seattle, WA 183 Early Versus Late Causes of Allograft Failures in 125 Orthotopic Liver Transplants (1243) B Bhattacharya, S Cotler, M Torbensen, S Jakate - Johns Hopkins Hospital, Baltimore, MD; University of Illinois, Chicago, IL; Rush-Presbyterian St. Luke's Medical Center, Chicago, IL 184 Centrilobular Necrosis in Posttransplant Liver Biopsies: Etiologic Correlations and Clinical Outcome (1285) M Krishna, RE Nakhleh - Mayo Clinic Jacksonville, Jacksonville, FL 185 Clinicopathologic Outcome of 30 Patients with Cadaveric Split Liver Allografts (1284) M Krishna, WR Hewitt, RE Nakhleh - Mayo Clinic Jacksonville, Jacksonville, FL 186 Liver Transplantation for Severe Intrahepatic Non-Cirrhotic Portal Hypertension (1283) AM Krasinskas, EE Furth, SC Abraham - University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pennsylvania Medical Center, Philadelphia, PA; Mayo Clinic, Rochester, MN 187 A Longstanding Misconception: Cytokeratin 7 and Cytokeratin 20 Expression in Hepatocellular Carcinoma (1242) A Auerbach, KG Ishak, ZD Goodman - The Armed Forces Institute of Pathology, Washington, DC 188 Survival and Immunohistochemical Features of Fibrolamellar Carcinoma: Comparison with Conventional Hepatocellular Carcinoma with and without Cirrhosis (1273) S Kakar, LJ Burgart, J Garcia, KP Batts, D Jain, L Ferrell - UCSF and VA Medical Center, San Francisco, CA; Mayo Clinic, Rochester, MN; Abbott Northwestern Hospital, Minneapolis, MN; Yale University, New Haven, CT 189 Effectiveness of Radio Frequency Ablation of Hepatocellular Carcinoma (HCC) Prior to Liver Transplantation: A Single Center Experience Update (1277) N Katabi, R Goldstein, B Altrabulsi, P Martin, K Burt, M Levy, E Sanchez, D Watkins, G Klintmalm, G Netto - Baylor University Medical Ctr, Dallas, TX 190 Liver Fibrosis and Clinicopathologic Characteristics of Hepatocellular Carcinoma (1315) H Varnholt, M Mino, B Terris, KP Batts, H Yamabe, GY Lauwers - Massachusetts General Hospital, Boston, MA; Hopital Beaujon, Paris, France; Mayo Clinic, Rochester, MN; Kyoto University, Kyoto, Japan 191 Tissue Microarray Analysis of EGFR1 Expression in Hepatocellular Carcinoma (1253) SA El-Zayaty, LM Yerian, C Gong, RA Anders, J Hart - University of Chicago, Chicago, IL 192 Endothelialitis in Chronic Viral Hepatitis: Not an Uncommon Finding (1319) MM Yeh, AM Larson, M Emond, K Kowdley, B Tung, PE Swanson, MP Upton - University of Washington School of Medicine, Seattle, WA 193 Transforming Growth Factor-alpha and Liver Carcinogenesis: An Immunohistochemical Study of 52 Cases (1320) MM Yeh, JS Campbell, N Fausto, PE Swanson - University of Washington School of Medicine, Seattle, WA 194 Thyroid Transcription Factor-1 as a Useful Marker in the Differential Diagnosis of Hepatocellular Carcinoma from Cholangiocarcinoma and Metastatic Carcinoma in the Liver (1286) JY Lei, PA Bourne, J Huang, PA diSant'Agnese - University of Rochester Medical Center, Rochester, NY 195 P70 S6 Kinase and mTOR Expression in Hepatocellular Carcinoma and Hepatic Adenomas (1308) F Sahin, O Adegbola, R Kannangai, J Wang, M Torbenson - Johns Hopkins, Baltimore, MD; AmeriPath Inc, Orlando, FL 196 Expression of B-Catenin in Hepatocellular Carcinomas and Hepatoblastomas (1272) HR Jung, YN Kang, SY Kwon, HK Oh, SP Kim, KK Park, KY Kwon, SS Lee - Keimyung University School of Medicine, Daegu, Korea 197 Mutations of b-Catenin and AXIN I Are Late Event in Human Hepatocellular Carcinogenesis (1313) CO Sung, JY Park, JY Lee, CK Park - Sungkyunkwan University School of Medicine, Seoul, Korea; College of Medicine Catholic University of Korea, Seoul, Korea 198 Inactivatin of CDP-Diacylglycerol Synthase 1 (CDS1) by Methylation in Hepatocellular Carcinoma (1245) JH Chang, KT Yeh, JG Chang - Chang-Hua Christian Hospital, Chang-Hua City, Taiwan; China Medical College, Taichung City, Taiwan 199 FHIT mRNA and Protein Expression in Hepatocellular Carcinoma and Other Primary Hepatic Neoplasms (1275) R Kannangai, F Sahin, O Adegbola, R Ashfaq, M Torbenson - Johns Hopkins, Baltimore, MD; University of Texas Southwestern Medical Center, Dallas, TX 200 Immunohistochemistry Can Help Distinguish Metastatic Pancreatic Adenocarcinomas from Bile Duct Adenomas and Hamartomas of the Liver (1267) JL Hornick, GY Lauwers, RD Odze - Brigham and Women's Hospital; Massachusetts General Hospital, Boston, MA 201 Focal Nodular Hyperplasia of the Liver: Association with Vascular Abnormalities and with Hepatic Adenoma (1270) D Jevremovic, TC Smyrk, SC Abraham - Mayo Clinic, Rochester, MN